DOI: 10.1111/acem.70366 ISSN: 1069-6563

Predicting Echocardiography Findings in Adults Presenting to the Emergency Department With Syncope: An External Validation of the ROMEO Score

John DeAngelis, Gymar Vargas, Robert E. Weiss, Carolyn Winskill, Edward H. Suh, Dana L. Sacco, Nancy Wood, Daniel K. Nishijima, Alan B. Storrow, Jonathan Schimmel, Timothy J. Poterucha, Pierre A. Elias, Nataly Beltre, Marc A. Probst

ABSTRACT

Background

Syncope is common in the Emergency Department (ED) and can be associated with structural heart disease (SHD). Transthoracic echocardiography (TTE) is commonly ordered to assess for SHD.

Objective

To externally validate the previously developed ROMEO score, which identifies patients with syncope who are at very low risk of significant findings on TTE.

Design

Secondary analysis of a multicenter, prospective, observational cohort study.

Setting

One community and five academic EDs in the United States.

Participants

Adults (≥ 40 years old) presenting to the ED with syncope or presyncope, without a serious ED diagnosis.

Interventions

Receipt of TTE within 30 days of the index visit.

Measurements

Our primary outcome was the rate of significant findings on TTE within 30 days of the index ED visit. We calculated the sensitivity, specificity, negative and positive predictive values (NPV, PPV), and the area under the curve (AUC) of the ROMEO score.

Results

We enrolled 1287 patients, of whom 427 underwent TTE. 88 (20.6%) had a significant finding. A ROMEO score of zero had a sensitivity of 98.9% and a NPV of 98.6%. The specificity and PPV were 20.2% and 24.3%, respectively. The AUC was 0.83 (95% CI: 0.79 to 0.87).

Limitations

Given the rate of non‐enrollment of screened patients, there is potential for selection bias. Our study sample was biased toward urban, academic centers; the results may not apply to community settings.

Conclusions

The ROMEO score demonstrates strong predictive performance and may be useful to help clinicians identify patients who are unlikely to benefit from TTE.

Trial Registration

ClinicalTrial.gov identifier: NCT04533425

More from our Archive